These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1499556)

  • 21. Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate.
    Barnaud G; Labia R; Raskine L; Sanson-Le Pors MJ; Philippon A; Arlet G
    FEMS Microbiol Lett; 2001 Feb; 195(2):185-90. PubMed ID: 11179650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple substitutions at position 104 of beta-lactamase TEM-1: assessing the role of this residue in substrate specificity.
    Petit A; Maveyraud L; Lenfant F; Samama JP; Labia R; Masson JM
    Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):33-40. PubMed ID: 7826350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of cefpirome and a cephalosporinase from Citrobacter freundii GN7391.
    Satake S; Hiraoka M; Mitsuhashi S
    Antimicrob Agents Chemother; 1989 Mar; 33(3):398-9. PubMed ID: 2658787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of an amino acid insertion into the omega loop region of a class C beta-lactamase on its substrate specificity.
    Nukaga M; Taniguchi K; Washio Y; Sawai T
    Biochemistry; 1998 Jul; 37(29):10461-8. PubMed ID: 9671516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of E1040 with cephalosporinase from Citrobacter freundii GN7391.
    Inoue E; Mitsuhashi S
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2157-9. PubMed ID: 2694954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unexpected advanced generation cephalosporinase activity of the M69F variant of SHV beta-lactamase.
    Helfand MS; Hujer AM; Sönnichsen FD; Bonomo RA
    J Biol Chem; 2002 Dec; 277(49):47719-23. PubMed ID: 12354765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substitution of Alanine at Position 184 with Glutamic Acid in Escherichia coli PBP5 Ω-Like Loop Introduces a Moderate Cephalosporinase Activity.
    Kar D; Pandey SD; Mallick S; Dutta M; Ghosh AS
    Protein J; 2018 Apr; 37(2):122-131. PubMed ID: 29549627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Critical hydrogen bonding by serine 235 for cephalosporinase activity of TEM-1 beta-lactamase.
    Imtiaz U; Manavathu EK; Lerner SA; Mobashery S
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2438-42. PubMed ID: 8285630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of a cefepime- and cefpirome-resistant Citrobacter freundii clinical isolate harbouring a novel chromosomally encoded AmpC beta-lactamase, CMY-37.
    Ahmed AM; Shimamoto T
    Int J Antimicrob Agents; 2008 Sep; 32(3):256-61. PubMed ID: 18619820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Site-directed mutagenesis of dicarboxylic acids near the active site of Bacillus cereus 5/B/6 beta-lactamase II.
    Lim HM; Iyer RK; Pène JJ
    Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):401-4. PubMed ID: 1904717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification and properties of chromosomally mediated beta-lactamase from Citrobacter freundii GN7391.
    Tajima M; Takenouchi Y; Sugawara S; Inoue M; Mitsuhashi S
    J Gen Microbiol; 1980 Dec; 121(2):449-56. PubMed ID: 6973612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of beta-lactamases of the penicillinase type.
    Jaurin B; Grundström T
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):4897-901. PubMed ID: 6795623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inducible expression of the chromosomal cdiA from Citrobacter diversus NF85, encoding an ambler class A beta-lactamase, is under similar genetic control to the chromosomal ampC, encoding an ambler class C enzyme, from Citrobacter freundii OS60.
    Jones ME; Bennett PM
    Microb Drug Resist; 1995; 1(4):285-91. PubMed ID: 9158798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic studies on inactivation of Citrobacter freundii cephalosporinase by sulbactam.
    Yamaguchi A; Hirata T; Sawai T
    Antimicrob Agents Chemother; 1983 Jul; 24(1):23-30. PubMed ID: 6312873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymes.
    Hujer KM; Hamza NS; Hujer AM; Perez F; Helfand MS; Bethel CR; Thomson JM; Anderson VE; Barlow M; Rice LB; Tenover FC; Bonomo RA
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2941-8. PubMed ID: 15980372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of methoxy-substitution of beta-lactam compounds on the interaction with various beta-lactamases.
    Cullmann W; Dick W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Nov; 256(1):109-18. PubMed ID: 6362278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression system and biochemical profile of CTX-M-3 extended-spectrum beta-lactamase expressed in Escherichia coli.
    Perilli M; Ettorre D; Segatore B; Caporale B; De Santis F; Pochetti G; Brigante G; Mazza F; Tavìo MM; Amicosante G
    FEMS Microbiol Lett; 2004 Dec; 241(2):229-32. PubMed ID: 15598537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Site-directed mutagenesis of beta-lactamase TEM-1. Investigating the potential role of specific residues on the activity of Pseudomonas-specific enzymes.
    Lenfant F; Petit A; Labia R; Maveyraud L; Samama JP; Masson JM
    Eur J Biochem; 1993 Nov; 217(3):939-46. PubMed ID: 8223651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Covalent binding of moxalactam to cephalosporinase of Citrobacter freundii.
    Murakami K; Yoshida T
    Antimicrob Agents Chemother; 1985 May; 27(5):727-32. PubMed ID: 3874595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substitution of Met-69 by Ala or Gly in TEM-1 beta-lactamase confer an increased susceptibility to clavulanic acid and other inhibitors.
    Madec S; Blin C; Krishnamoorthy R; Picard B; Chaibi el B; Fouchereau-Péron M; Labia R
    FEMS Microbiol Lett; 2002 May; 211(1):13-6. PubMed ID: 12052544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.